Grupo LifEscozul® · Biomedical & Biotech Platform
High-impact editorial web design and scientific authority platform for blue scorpion biological protocol with U.S. FDA NDC registration and WIPO patents.
01 / Overview
Grupo LifEscozul® (Blue Scorpion Group Inc.) is a biotechnology and biomedical research firm specializing in natural bioactive compounds from the blue scorpion (Rhopalurus junceus), led by Dr. Alexis Díaz. We designed a sophisticated, high-authority digital presence highlighting 18 years of clinical investigation, international agreements, and official U.S. FDA registration.
02 / The Challenge
The primary challenge was projecting indisputable scientific rigor, clinical validation, and regulatory compliance while breaking free from outdated pharmaceutical aesthetic tropes, establishing instant trust for both patients and the international scientific community.
03 / The Solution
Created an editorial dark-mode interface in Figma using deep midnight blues and vibrant bioluminescent cyan accents. Implemented classical serif typography for academic prestige, a prominent scientific credibility metrics bar (peer-reviewed articles, FDA NDC registration, documented cases), and direct conversion pathways for protocol inquiries.
04 / Key Deliverables
- ✦Complete UI/UX design (Desktop & Mobile) in Figma
- ✦Biotech dark-mode design system and visual token library
- ✦Evidence-based clinical information architecture
- ✦Scientific credibility dashboard (FDA NDC, publications, patents)
- ✦Visual art direction and laboratory photography curation
- ✦Optimized protocol inquiry and patient conversion funnels
05 / Impact & Metrics
Visual Gallery & Details
Click to expand
